← All indications
Pneumonia, Pneumocystis
A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
Drugs by status
Approved for this indication (4)
Phase 4 trials (8)
Phase 3 trials (8)
Phase 2 trials (4)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (22)
- Glaxo Wellcome
- National Institute of Allergy and Infectious Diseases (NIAID)
- Liaocheng People's Hospital
- Shandong Provincial Hospital
- Shandong Provincial Institute of Dermatology and Venereology
- University of Bergen
- Shandong Province Qianfoshan Hospital
- Jinan University
- Muhimbili University
- George Washington University
- Western Norway Regional Health Authority
- Qingdao Center Medical Group
- Dongying People's Hospital, Shandong
- Shandong Jining No. 1 People's Hospital
- Dezhou People's Hospital,Shandong
- Linyi City Dermatology Hospital Prevention and Treatment
- Jining City Dermatology Hospital Prevention and Treatment
- Weifang City Dermatology Hospital Prevention and Treatment
- Laiwu City Dermatology Hospital Prevention and Treatment
- Rizhao City Dermatology Hospital Prevention and Treatment
- People's Liberation Army of China
- Chinese Academy of Medical Sciences
Organization Involved with Phase 3 Indications (21)
- Jacobus Pharmaceutical
- Fujisawa
- Upjohn
- Immtech Pharmaceuticals, Inc
- Henry Ford Health System
- New York University
- University of Medicine and Dentistry of New Jersey
- University of Miami
- Fudan University
- University of California, San Francisco
- University of Chicago
- University of Cincinnati
- Medical University of South Carolina
- Tsinghua University
- University of the Witwatersrand
- Cidara Therapeutics
- University of North Carolina at Chapel Hill
- University of Paris
- Comprehensive International Program of Research on AIDS
- Secure the Future Foundation
- National Institute of Child Health and Human Development (NICHD)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Other Experimental Indications (9)